Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00223483 · ClinicalTrials.gov registry record
Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 512
- Enrollment target
NCT00223483: Completed study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT00223483 is a clinical trial that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 512 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00223483 has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 512 participants
- Enrollment target
Study Summary
This research study goal is to analyze the plasma and the cells that make up part of the immune system. We want to learn how the plasma and cells work. These may influence why one person will develop an infection and another will not, or why one person develops severe symptoms of a disease while others remain without symptoms.
Interventions
- GENETIC Isolation of genomic DNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2005-03 |
| Est. Completion | 2021-07-14 |
What the finished NCT00223483 record still lists
NCT00223483 is an observational study that tracks outcomes without assigning an intervention. The registered 512 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Isolation of genomic DNA is the first listed.
NCT00223483 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00223483 about?
NCT00223483 is a clinical study titled "Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers". This research study goal is to analyze the plasma and the cells that make up part of the immune system. We want to learn how the plasma and cells work. These may influence why one person will develop an infection and another will not, or why one person develops severe symptoms of a disease while oth...
What is the current status of trial NCT00223483?
This trial is currently completed. The enrollment target is 512 participants. The study started on 2005-03. Estimated completion is 2021-07-14.
What interventions are being tested in trial NCT00223483?
The interventions under investigation include: Isolation of genomic DNA (GENETIC).
Who is sponsoring clinical trial NCT00223483?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia